Leap Therapeutics
Price & Volume
Stats
See moreOpen | $2.58 |
Previous Close | $2.55 |
Day Range | $2.53-$2.61 |
52W Range | $1.68-$5 |
Market Cap | $97.7M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $375,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $1.5M |
Diluted EPS | -$1.64 |
News
See moreYahoo Finance • last year
Leap Therapeutics Announces Initiation of Randomized Controlled Part B of the DeFianCe Study of DKN-01 in Colorectal Cancer Patients
Yahoo Finance • 2 years ago
BeiGene Will Not Go Forward With Licensing Pact For Leap Therapeutics' Lead Cancer Candidate
Yahoo Finance • 2 years ago
Moore Kuehn Encourages ALBO, LPTX, ALR, and CEMI Investors to Contact Law Firm
Yahoo Finance • 2 years ago
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AQUA, LPTX, ALR
About
CEO | Mr. Douglas E. Onsi J.D. |
CFO | Mr. Douglas E. Onsi J.D. |
Address | 47 Thorndike Street, Cambridge, MA, United States, 02141 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 54 |
